サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1225157

医薬品ろ過の世界市場：製品別 (膜、デプスフィルター)・システム別 (使い捨て型、再利用型)・技術別 (精密/ナノろ過)・用途別 (API (医薬品原薬)、ワクチン、抗体)・事業規模別 (製造、パイロット、研究開発 (R&D))・地域別の将来予測 (2028年)

Pharmaceutical Filtration Market by Product (Membrane, Depth filter), System (Single use, Reusable), Technique(Micro/Nanofiltration), Application(API, Vaccine, Antibody), Scale of Operation (Manufacturing, Pilot, R&D) & Region -Global Forecasts -2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 433 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医薬品ろ過の世界市場：製品別 (膜、デプスフィルター)・システム別 (使い捨て型、再利用型)・技術別 (精密/ナノろ過)・用途別 (API (医薬品原薬)、ワクチン、抗体)・事業規模別 (製造、パイロット、研究開発 (R&D))・地域別の将来予測 (2028年)
出版日: 2023年02月13日
発行: MarketsandMarkets
ページ情報: 英文 433 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の医薬品ろ過の市場規模は、予測期間中に14.2%のCAGRで成長し、2023年には約135億米ドル、2028年には262億米ドルに達すると予測されています。

市場の主な促進要因として、中国・インド・ブラジル・メキシコといった新興国における大きな成長機会の提供や、ナノファイバー技術の進歩、医薬品・バイオテクノロジー産業における製造・研究開発の拡大などが挙げられます。

製品別では、2022年にシステム部門は2番目に大きなシェアを占めています。その要因の一つとして、分離・精製用途の重要性が高まっていることが挙げられます。

技術別では、限外ろ過 (UF) 技術が2022年に2番目に大きな市場シェアを占めています。その要因として、細胞採取と酵素精製血漿分離のための限外ろ過の実装などが挙げられます。

種類別では、2022年に無菌ろ過技術が最大のシェアを押さえています。その要因として、生物製剤の急成長、生物製剤の液体処理中の無菌ろ過の要件の急増、無菌ろ過の非無菌ろ過に対する利点などが挙げられます。

地域別に見ると、アジア太平洋が最も成長率の高い地域となっています。ウイルス性疾患の発生率の増加、厳しい規制ルールによるクリーンな製造環境の維持の必要性、ジェネリック医薬品製造の急速な拡大、ナノファイバー技術の開発、バイオ医薬品プロジェクトに対する研究開発費の増加、新興国におけるバイオテクノロジー産業の成長などが、市場成長の促進材料となっています。

当レポートでは、世界の医薬品ろ過の市場について分析し、市場の基本構造や最新情勢、主な市場促進・抑制要因、製品別・技術別・用途別・種類別・事業規模別・地域別の市場動向の見通し、市場競争の状態、主要企業のプロファイルなどを調査しております。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 範囲/シナリオ
  • 顧客のビジネスに影響を与える動向/混乱
  • 価格分析
  • バリューチェーン分析
  • サプライチェーン分析
  • エコシステム分析
  • 特許分析
  • ケーススタディ分析
  • 主な会議とイベント (2023年)
  • 規制分析
  • ポーターのファイブフォース分析
  • 主な利害関係者と購入基準

第6章 医薬品ろ過市場：製品別

  • イントロダクション
  • フィルター
    • 膜フィルター
    • デプスフィルター
    • その他のフィルター
  • システム
    • 使い捨て型システム
    • 再利用型システム
  • その他のろ過製品
    • ろ過用アセンブリ
    • フィルターホルダー
    • ろ過用アクセサリー

第7章 医薬品ろ過市場：技術別

  • イントロダクション
  • 精密ろ過
  • 限外ろ過
  • ナノろ過
  • その他の技術

第8章 医薬品ろ過市場：用途別

  • イントロダクション
  • 最終製品の処理
    • 医薬品原薬 (API) ろ過
    • タンパク質精製
    • ワクチン・抗体処理
    • 処方・充填溶液
    • ウイルス除去
  • 原材料のろ過
    • メディアバッファーろ過
    • 予備ろ過
    • バイオバーデン試験
  • 細胞分離
  • 水質浄化
  • 空気清浄

第9章 医薬品ろ過市場：種類別

  • イントロダクション
  • 滅菌ろ過
  • 非滅菌ろ過

第10章 医薬品ろ過市場：事業規模別

  • イントロダクション
  • 製造規模の運用
  • パイロット規模の運用
  • 研究開発 (R&D) 規模の運用

第11章 医薬品ろ過市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • 他の欧州諸国
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • 他のアジア太平洋諸国
  • ラテンアメリカ
    • ブラジル
    • 他のラテンアメリカ諸国
  • 中東・アフリカ

第12章 競合情勢

  • イントロダクション
  • 主要企業が採用した権利獲得アプローチ
  • 市場シェア分析
  • 収益分析
  • 企業評価マトリックス
  • 上位25社の競合ベンチマーキング
    • 企業の全体的なフットプリント (25社)
    • 企業の製品フットプリント (25社)
    • 企業の技術フットプリント (25社)
    • 企業の地域フットプリント (25社)
  • 企業評価マトリックス：スタートアップ/中小企業
  • 新興企業/中小企業の競合ベンチマーキング
  • 競合シナリオと動向
    • 製品の発売
    • 資本取引
    • 拡張

第13章 企業プロファイル

  • 主要企業
    • MERCK KGAA
    • DANAHER CORPORATION
    • SARTORIUS AG
    • PARKER HANNIFIN CORPORATION
    • EATON CORPORATION PLC
    • THERMO FISHER SCIENTIFIC, INC.
    • 3M COMPANY
    • DONALDSON COMPANY, INC.
    • REPLIGEN CORPORATION
    • PORVAIR PLC
    • ALFA LAVAL CORPORATE AB
    • CORNING INCORPORATED
    • MEISSNER FILTRATION PRODUCTS, INC.
    • AMAZON FILTERS LTD.
    • GRAVER TECHNOLOGIES, LLC.
  • その他の企業
    • MMS AG
    • MANN+HUMMEL INTERNATIONAL GMBH & CO. KG
    • ERTELALSOP
    • KASAG SWISS AG
    • FREUDENBERG FILTRATION TECHNOLOGIES SE & CO. KG
    • COLE-PARMER INSTRUMENT COMPANY, LLC
    • CANTEL MEDICAL CORP.
    • FILTROX AG
    • SAINT-GOBAIN PERFORMANCE PLASTICS
    • MEMBRANE SOLUTIONS

第14章 付録

目次
Product Code: BT 4058

The pharmaceutical filtration market is expected to grow at a CAGR of 14.2% during the forecast period. The market is estimated to be around USD 13.5 billion in 2023 and is projected to reach USD 26.2 billion by 2028. Growth in the pharmaceutical filtration market can be attributed to factors such as emerging countries like China, India, Brazil, and Mexico offering significant growth opportunities, advancement in nanofiber technology, and increased manufacturing and R&D in the pharmaceutical & biotechnology industries. On the other hand, membrane fouling and the growing capital investment required to set up new production facilities are expected to hinder market growth.

"In 2022 the systems segment accounted for the second largest share of the pharmaceutical market"

Based on products, the pharmaceutical filtration market is segmented into major three segments, namely, filters, systems, and other products. The filter market is further segmented into membrane filters, depth filters, and other filters, such as prefilters, bag filters, and magnetic filters. The systems market is further segmented into single-use systems and reusable systems. In 2022 the systems segment accounted for the second largest share of the pharmaceutical market. The large share of this segment can primarily be attributed rising importance of separation and purification applications. Developments in research techniques and increased demand for more specificity in the filtration process are increasing the adoption of single-use technologies in many small-scale biopharmaceutical processes.

"The ultrafiltration techniques accounted for the second largest market share of this market in 2022"

Based on technique, the pharmaceutical filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other techniques. The other techniques segment includes reverse osmosis and ion exchange. The microfiltration techniques accounted for the second largest market share of this market in 2022, and this can be primarily attributed to the implementation of ultrafiltration for cell harvesting and enzyme purification plasma separation. It is also used in the filtration of active pharmaceutical ingredients, media & buffers, formulations, and filling solutions. To a certain extent, UF allows the removal of viruses, phage, colloids, and macromolecules, which cannot be achieved with microfiltration and hence is acquiring large share in the market.

"The sterile filtration technique accounted for the largest market share of this market in 2022"

Based on type, the pharmaceutical filtration market is segmented into sterile filtration and non-sterile filtration. The sterile filtration technique accounted for the largest market share of this market in 2022, and this can be attributed the factors such as the fast growth of biologics, the rapid increase in the requirement of sterile filtration during the liquid processing of biopharmaceuticals, and the benefits of sterile filtration over non-sterile filtration.

Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US), Eaton Corporation plc (US), Donaldson Company, Inc. (US), Repligen Corporation (US), Porvair plc (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), Meissner Filtration Products, Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies, LLC (US), MMS AG (Switzerland), MANN+HUMMEL International GmbH & Co. KG (Germany), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company, LLC. (US), Cantel Medical Corp. (US), Filtrox AG (Switzerland), Saint-Gobain Performance Plastics (France), and Membrane Solutions (US) are some of the major players operating in the pharmaceutical filtration market.

"Asia Pacific: The fastest-growing region in the pharmaceutical filtration market"

The pharmaceutical filtration market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the growing incidence rate of viral diseases, the requirement to maintain a clean manufacturing environment because of strict foreign regulatory rules, the fast expansion of generics manufacturing, developments in nanofiber technologies, increasing R&D spending on biopharmaceutical projects, and the growth of the biotechnology industry in developing countries.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 80% and Demand Side - 20%
  • By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
  • By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%

List of Companies Profiled in the Report:

  • Merck KGaA (Germany)
  • Danaher Corporation (US)
  • Sartorius AG (Germany)
  • Parker-Hannifin Corporation (US)
  • Thermo Fisher Scientific Inc. (US)
  • 3M Company (US)
  • Eaton Corporation plc (US)
  • Donaldson Company, Inc. (US)
  • Repligen Corporation (US)
  • Porvair plc (UK)
  • Alfa Laval Corporate AB (Sweden)
  • Corning Incorporated (US)
  • Meissner Filtration Products, Inc. (US)
  • Amazon Filters Ltd. (UK)
  • Graver Technologies, LLC (US)
  • MMS AG (Switzerland)
  • MANN+HUMMEL International GmbH & Co. KG (Germany)
  • ErtelAlsop (US)
  • Kasag Swiss AG (Switzerland)
  • Freudenberg Filtration Technologies SE & Co. KG (Germany)
  • Cole-Parmer Instrument Company, LLC. (US)
  • Cantel Medical Corp. (US)
  • Filtrox AG (Switzerland)
  • Saint-Gobain Performance Plastics (France)
  • Membrane Solutions (US)

Research Coverage:

This report provides a detailed picture of the pharmaceutical filtration market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical filtration market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES, BY RESPONDENT, DESIGNATION, AND REGION
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 PHARMACEUTICAL FILTRATION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
    • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 6 PHARMACEUTICAL FILTRATION MARKET (SUPPLY SIDE): CAGR PROJECTIONS
    • FIGURE 7 PHARMACEUTICAL FILTRATION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
    • 2.3.1 DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 IMPACT OF RECESSION
    • TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2024-2027 (% GROWTH)
  • 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 9 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL FILTRATION MARKET

4 PREMIUM INSIGHTS

  • 4.1 PHARMACEUTICAL FILTRATION MARKET OVERVIEW
    • FIGURE 15 INCREASING R&D SPENDING IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT AND COUNTRY (2022)
    • FIGURE 16 FILTERS SEGMENT TO POSSESS LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL FILTRATION MARKET IN 2022
  • 4.3 PHARMACEUTICAL FILTRATION MARKET SHARE, BY APPLICATION (2023 VS. 2028)
    • FIGURE 17 FINAL PRODUCT PROCESSING APPLICATIONS SEGMENT TO DOMINATE MARKET IN 2028
  • 4.4 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2022 (USD MILLION)
    • FIGURE 18 MICROFILTRATION SEGMENT TO DOMINATE MARKET, BY TECHNIQUE, IN 2022
  • 4.5 PHARMACEUTICAL FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2028

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 PHARMACEUTICAL FILTRATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 2 PHARMACEUTICAL FILTRATION MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing biopharmaceutical industry
    • TABLE 3 INDICATIVE LIST OF BIOLOGICAL LICENSE APPLICATION APPROVALS, 2021 AND 2022
      • 5.2.1.2 Rising R&D spending in pharmaceutical and biotechnology industries
    • FIGURE 21 GLOBAL PHARMACEUTICAL R&D SPENDING, 2014-2028
      • 5.2.1.3 Increasing adoption of single-use technologies
      • 5.2.1.4 New product launches by leading market players
      • 5.2.1.5 Increasing purity requirements in end-user segments
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Membrane fouling issues
      • 5.2.2.2 Requirement of high capital investments for new production facilities
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging economies
      • 5.2.3.2 Advances in nanofiber technology
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Increased cost and reduced speed and yield of filters
      • 5.2.4.2 Survival of small players and new entrants
  • 5.3 RANGES/SCENARIOS
    • FIGURE 22 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PHARMACEUTICAL FILTRATION MARKET
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PHARMACEUTICAL FILTRATION PRODUCT PROVIDERS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS
    • TABLE 4 PRICE OF PHARMACEUTICAL FILTRATION PRODUCTS (2022)
    • 5.5.2 AVERAGE SELLING PRICE TREND
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 24 VALUE CHAIN ANALYSIS OF PHARMACEUTICAL FILTRATION MARKET
  • 5.7 SUPPLY CHAIN ANALYSIS
    • FIGURE 25 PHARMACEUTICAL FILTRATION MARKET: SUPPLY CHAIN ANALYSIS
  • 5.8 ECOSYSTEM ANALYSIS
    • FIGURE 26 ECOSYSTEM ANALYSIS: PHARMACEUTICAL FILTRATION MARKET
    • TABLE 5 SUPPLY CHAIN ECOSYSTEM
  • 5.9 PATENT ANALYSIS
    • FIGURE 27 PATENT APPLICATIONS FOR PHARMACEUTICAL FILTRATION MARKET, JANUARY 2012-DECEMBER 2022
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 IMPROVED CAPACITY AND EFFICIENCY OF CARBON REMOVAL PROCESS FROM ACTIVE PHARMACEUTICAL INGREDIENTS
    • 5.10.2 FILTER HOUSING CAPABLE OF HANDLING BOTH GAS AND LIQUID
    • 5.10.3 3M OFFERS EMPHAZE AEX HYBRID PURIFIER TO REDUCE IMPURITIES IN BIOPHARMACEUTICAL DOWNSTREAM PROCESS
    • 5.10.4 DELIVERY OF POLYPROPYLENE PLEATED CARTRIDGES FOR HIGH-PURITY PHARMACEUTICAL PRODUCTS
    • 5.10.5 USE OF POLYPROPYLENE HIGH-FLOW CARTRIDGE FOR FINAL FILTRATION PROCESS
  • 5.11 KEY CONFERENCES AND EVENTS IN 2023
    • TABLE 6 PHARMACEUTICAL FILTRATION MARKET: LIST OF CONFERENCES AND EVENTS
  • 5.12 REGULATORY ANALYSIS
    • 5.12.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES
    • 5.12.2 REGULATORY SCENARIO IN DIFFERENT REGIONS/COUNTRIES
  • 5.13 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 PHARMACEUTICAL FILTRATION MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.13.1 THREAT OF NEW ENTRANTS
    • 5.13.2 THREAT OF SUBSTITUTES
    • 5.13.3 BARGAINING POWER OF BUYERS
    • 5.13.4 BARGAINING POWER OF SUPPLIERS
    • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN PHARMACEUTICAL COMPANIES AND THEIR INFLUENCE ON BUYING PROCESS
    • FIGURE 28 INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL COMPANIES ON BUYING PROCESS OF PHARMACEUTICAL FILTRATION PRODUCTS
    • 5.14.2 KEY BUYING CRITERIA FOR PHARMACEUTICAL FILTRATION PRODUCTS AMONG END USERS
    • FIGURE 29 KEY BUYING CRITERIA FOR END USERS

6 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 8 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 FILTERS
    • TABLE 9 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 10 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 11 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 12 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 13 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 14 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 6.2.1 MEMBRANE FILTERS
    • TABLE 15 GLOBAL PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 16 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 18 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 19 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 20 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
      • 6.2.1.1 Polyethersulfone (PES)
    • TABLE 21 GLOBAL PES MEMBRANE FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 22 NORTH AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 23 EUROPE: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 24 ASIA PACIFIC: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 LATIN AMERICA: PES MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.2 Polyvinylidene difluoride (PVDF)
        • 6.2.1.2.1 FDA, USP, and EEC compliance to increase demand for PVDF filters
    • TABLE 26 GLOBAL PVDF MEMBRANE FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 27 NORTH AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 EUROPE: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 29 ASIA PACIFIC: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 30 LATIN AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.3 Nylon
        • 6.2.1.3.1 Increased endotoxin adsorption capacity of nylon filters to drive growth
    • TABLE 31 GLOBAL NYLON MEMBRANE FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 32 NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 33 EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 35 LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.4 Polytetrafluoroethylene (PTFE)
        • 6.2.1.4.1 PTFE membrane filters offer retention of ratings as fine as 0.01μ
    • TABLE 36 GLOBAL PTFE MEMBRANE FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 37 NORTH AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 EUROPE: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 39 ASIA PACIFIC: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 40 LATIN AMERICA: PTFE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.5 Mixed cellulose ester & cellulose acetate (MCE & CA)
        • 6.2.1.5.1 MCE membranes widely used in analytical and research applications
    • TABLE 41 GLOBAL MCE & CA MEMBRANE FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 42 NORTH AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 43 EUROPE: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 ASIA PACIFIC: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 45 LATIN AMERICA: MCE & CA MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.6 Polycarbonate track-etched (PCTE)
        • 6.2.1.6.1 PCTE membrane filters widely used in cell biology and analytical testing applications
    • TABLE 46 GLOBAL PCTE MEMBRANE FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 47 NORTH AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 48 EUROPE: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 ASIA PACIFIC: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 LATIN AMERICA: PCTE MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.1.7 Other materials
    • TABLE 51 GLOBAL OTHER MATERIAL MEMBRANE FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 52 NORTH AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 53 EUROPE: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 ASIA PACIFIC: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 LATIN AMERICA: OTHER MATERIAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.2 DEPTH FILTERS
    • TABLE 56 GLOBAL DEPTH FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 57 NORTH AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 58 EUROPE: DEPTH FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 59 ASIA PACIFIC: DEPTH FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 LATIN AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 61 DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
      • 6.2.2.1 Diatomaceous earth
        • 6.2.2.1.1 DE filters used in biotechnology industry for cell clarification
    • TABLE 62 GLOBAL DIATOMACEOUS EARTH FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 63 NORTH AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 EUROPE: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 65 ASIA PACIFIC: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 LATIN AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.2.2 Cellulose
        • 6.2.2.2.1 Cost-effectiveness of cellulose-based depth filters to drive growth
    • TABLE 67 GLOBAL CELLULOSE FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 68 NORTH AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 69 EUROPE: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 ASIA PACIFIC: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 LATIN AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.2.3 Activated carbon
        • 6.2.2.3.1 Reliable and economic activated carbon filters to be used in traditional pharmaceutical manufacturing operations
    • TABLE 72 GLOBAL ACTIVATED CARBON FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 73 NORTH AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 74 EUROPE: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 76 LATIN AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.2.4 Perlite
        • 6.2.2.4.1 Lower density of perlite provides more purity than diatomaceous earth
    • TABLE 77 GLOBAL PERLITE FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 78 NORTH AMERICA: PERLITE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 79 EUROPE: PERLITE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: PERLITE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 81 LATIN AMERICA: PERLITE FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • 6.2.2.5 Other depth filter media
    • TABLE 82 GLOBAL OTHER DEPTH FILTER MEDIA MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 83 NORTH AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 EUROPE: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 85 ASIA PACIFIC: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 86 LATIN AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.3 OTHER FILTERS
    • TABLE 87 GLOBAL OTHER PHARMACEUTICAL FILTERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 88 NORTH AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 89 EUROPE: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 90 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 91 LATIN AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 SYSTEMS
    • TABLE 92 GLOBAL FILTRATION SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 93 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 94 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 96 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 97 GLOBAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 6.3.1 SINGLE-USE SYSTEMS
      • 6.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost adoption
    • TABLE 98 GLOBAL SINGLE-USE FILTRATION SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 99 NORTH AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 100 EUROPE: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 102 LATIN AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.2 REUSABLE SYSTEMS
      • 6.3.2.1 Reusable systems widely used for large-scale manufacturing
    • TABLE 103 GLOBAL REUSABLE SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 104 NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 105 EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 107 LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 OTHER FILTRATION PRODUCTS
    • TABLE 108 OTHER FILTRATION PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 109 NORTH AMERICA: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 110 EUROPE: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 112 LATIN AMERICA: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 113 OTHER FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 6.4.1 FILTRATION ASSEMBLIES
      • 6.4.1.1 Leading players provide pre-assembled filtration assemblies
    • TABLE 114 GLOBAL FILTRATION ASSEMBLIES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 115 NORTH AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 116 EUROPE: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 118 LATIN AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.4.2 FILTER HOLDERS
      • 6.4.2.1 Filter holders provide structural support to membrane filters
    • TABLE 119 GLOBAL FILTER HOLDERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 120 NORTH AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 121 EUROPE: FILTER HOLDERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: FILTER HOLDERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 123 LATIN AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.4.3 FILTRATION ACCESSORIES
      • 6.4.3.1 Increasing adoption of pharmaceutical filtration products to support growth
    • TABLE 124 GLOBAL PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 125 NORTH AMERICA: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 126 EUROPE: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 128 LATIN AMERICA: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

7 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE

  • 7.1 INTRODUCTION
    • TABLE 129 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
  • 7.2 MICROFILTRATION
    • 7.2.1 INCREASED ADOPTION OF MICROFILTRATION TO PROPEL MARKET GROWTH
    • TABLE 130 GLOBAL MICROFILTRATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 131 NORTH AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 132 EUROPE: MICROFILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 133 ASIA PACIFIC: MICROFILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 134 LATIN AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 ULTRAFILTRATION
    • 7.3.1 ADOPTION OF FINE FILTRATION TECHNIQUES TO DRIVE GROWTH
    • TABLE 135 GLOBAL ULTRAFILTRATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 136 NORTH AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 137 EUROPE: ULTRAFILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 138 ASIA PACIFIC: ULTRAFILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 139 LATIN AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 NANOFILTRATION
    • 7.4.1 HIGH ENERGY CONSUMPTION TO HINDER MARKET GROWTH
    • TABLE 140 GLOBAL NANOFILTRATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 141 NORTH AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 142 EUROPE: NANOFILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 143 ASIA PACIFIC: NANOFILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 144 LATIN AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 OTHER TECHNIQUES
    • TABLE 145 GLOBAL OTHER TECHNIQUES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 146 NORTH AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 147 EUROPE: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 148 ASIA PACIFIC: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 149 LATIN AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 150 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 FINAL PRODUCT PROCESSING
    • TABLE 151 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 152 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 153 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 154 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 155 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 156 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • 8.2.1 ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION
      • 8.2.1.1 Continuous requirement for API filtration to drive market growth
    • TABLE 157 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 158 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 159 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 160 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 161 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.2 PROTEIN PURIFICATION
      • 8.2.2.1 Recent advancements in protein therapeutic drugs to propel growth
    • TABLE 162 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 163 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 164 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 165 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 166 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.3 VACCINE AND ANTIBODY PROCESSING
      • 8.2.3.1 Development of vaccines for COVID-19 and other viral diseases to drive growth
    • TABLE 167 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 168 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 169 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 170 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 171 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.4 FORMULATION AND FILLING SOLUTIONS
      • 8.2.4.1 Demand for aseptic filling and bioburden reduction to propel growth
    • TABLE 172 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 173 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 174 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 175 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 176 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.5 VIRAL CLEARANCE
      • 8.2.5.1 Growing development of therapeutic monoclonal antibodies to drive market
    • TABLE 177 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 178 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 179 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 180 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 181 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 RAW MATERIAL FILTRATION
    • TABLE 182 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 183 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 184 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 185 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 186 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 187 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • 8.3.1 MEDIA BUFFER FILTRATION
      • 8.3.1.1 Growth in manufacturing of biopharmaceuticals to drive market
    • TABLE 188 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 189 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 190 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 191 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 192 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.3.2 PREFILTRATION
      • 8.3.2.1 Membrane fouling issues to drive growth
    • TABLE 193 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 194 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 195 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 196 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 197 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PREFILTRATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.3.3 BIOBURDEN TESTING
      • 8.3.3.1 Strict quality control of biopharmaceuticals to drive growth
    • TABLE 198 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 199 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 200 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 201 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 202 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 CELL SEPARATION
    • 8.4.1 GROWTH IN PERSONALIZED MEDICINE TO PROPEL MARKET
    • TABLE 203 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 204 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 205 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 206 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 207 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 WATER PURIFICATION
    • 8.5.1 GROWTH IN GERIATRIC POPULATION TO DRIVE MARKET
    • TABLE 208 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 209 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 210 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 211 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 212 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.6 AIR PURIFICATION
    • 8.6.1 INCREASING ADOPTION OF GMP PRACTICES TO DRIVE GROWTH
    • TABLE 213 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 214 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 215 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 216 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 217 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2021-2028 (USD MILLION)

9 PHARMACEUTICAL FILTRATION MARKET, BY TYPE

  • 9.1 INTRODUCTION
    • TABLE 218 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.2 STERILE FILTRATION
    • 9.2.1 ADVANTAGES OF STERILE FILTERS OVER NON-STERILE FILTERS TO DRIVE GROWTH
    • TABLE 219 GLOBAL STERILE FILTRATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 220 NORTH AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 221 EUROPE: STERILE FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 222 ASIA PACIFIC: STERILE FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 223 LATIN AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 NON-STERILE FILTRATION
    • 9.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO PROMOTE MARKET GROWTH
    • TABLE 224 GLOBAL NON-STERILE FILTRATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 225 NORTH AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 226 EUROPE: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 227 ASIA PACIFIC: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 228 LATIN AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

10 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION

  • 10.1 INTRODUCTION
    • TABLE 229 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
  • 10.2 MANUFACTURING-SCALE OPERATION
    • 10.2.1 GROWTH IN BIOLOGICS AND BIOSIMILARS MANUFACTURING TO DRIVE MARKET
    • TABLE 230 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 231 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 232 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 233 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 234 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.3 PILOT-SCALE OPERATION
    • 10.3.1 INCREASED OUTSOURCING TO DRIVE MARKET GROWTH
    • TABLE 235 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 236 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 237 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 238 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 239 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.4 R&D-SCALE OPERATION
    • 10.4.1 INCREASING INVESTMENTS IN R&D OF BIOLOGICS TO PROPEL GROWTH
    • TABLE 240 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 241 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 242 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 243 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 244 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2021-2028 (USD MILLION)

11 PHARMACEUTICAL FILTRATION MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 245 PHARMACEUTICAL FILTRATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 30 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT
    • TABLE 246 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 247 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 248 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 249 NORTH AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 250 NORTH AMERICA: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 251 NORTH AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 252 NORTH AMERICA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 253 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 254 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 255 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 256 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 257 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 258 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 US to dominate North American market during forecast period
    • FIGURE 31 US TO DOMINATE DISTRIBUTION OF R&D COMPANIES (2022)
    • TABLE 259 US: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 260 US: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 261 US: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 262 US: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 263 US: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 264 US: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 265 US: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 266 US: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 267 US: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 268 US: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 269 US: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 270 US: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Growing government support for expanding biologics manufacturing facilities to support market growth
    • TABLE 271 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 272 CANADA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 273 CANADA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 274 CANADA: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 275 CANADA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 276 CANADA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 277 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 278 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 279 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 280 CANADA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 281 CANADA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 282 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.2.3 NORTH AMERICA: RECESSION IMPACT
  • 11.3 EUROPE
    • TABLE 283 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 284 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 285 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 286 EUROPE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 287 EUROPE: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 288 EUROPE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 289 EUROPE: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 290 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 291 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 292 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 293 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 294 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 295 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 Growing pharmaceutical R&D and manufacturing to drive market
    • TABLE 296 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 297 GERMANY: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 298 GERMANY: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 299 GERMANY: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 300 GERMANY: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 301 GERMANY: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 302 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 303 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 304 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 305 GERMANY: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 306 GERMANY: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 307 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.3.2 UK
      • 11.3.2.1 Increased R&D investment and government aid to boost market growth
    • TABLE 308 UK: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 309 UK: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 310 UK: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 311 UK: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 312 UK: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 313 UK: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 314 UK: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 315 UK: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 316 UK: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 317 UK: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 318 UK: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 319 UK: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Government investment in pharmaceutical industry to drive growth
    • TABLE 320 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 321 FRANCE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 322 FRANCE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 323 FRANCE: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 324 FRANCE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 325 FRANCE: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 326 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 327 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 328 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 329 FRANCE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 330 FRANCE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 331 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.3.4 ITALY
      • 11.3.4.1 Investment in biotechnology R&D to boost market growth
    • TABLE 332 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 333 ITALY: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 334 ITALY: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 335 ITALY: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 336 ITALY: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 337 ITALY: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 338 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 339 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 340 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 341 ITALY: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 342 ITALY: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 343 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Expansion of biomanufacturing facilities to support market growth
    • TABLE 344 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 345 SPAIN: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 346 SPAIN: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 347 SPAIN: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 348 SPAIN: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 349 SPAIN: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 350 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 351 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 352 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 353 SPAIN: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 354 SPAIN: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 355 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.3.6 REST OF EUROPE
    • TABLE 356 ROE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 357 ROE: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 358 ROE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 359 ROE: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 360 ROE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 361 ROE: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 362 ROE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 363 ROE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 364 ROE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 365 ROE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 366 ROE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 367 ROE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.3.7 EUROPE: RECESSION IMPACT
  • 11.4 ASIA PACIFIC
    • FIGURE 32 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT
    • TABLE 368 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 369 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 370 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 371 ASIA PACIFIC: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 372 ASIA PACIFIC: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 373 ASIA PACIFIC: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 374 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 375 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 376 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 377 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 378 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 379 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 380 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.4.1 CHINA
      • 11.4.1.1 Shift from generic medicine to innovative drugs to drive market for advanced pharmaceutical filtration
    • TABLE 381 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 382 CHINA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 383 CHINA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 384 CHINA: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 385 CHINA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 386 CHINA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 387 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 388 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 389 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 390 CHINA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 391 CHINA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 392 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Stringent regulatory guidelines to create need for advanced filtration products
    • TABLE 393 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 394 JAPAN: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 395 JAPAN: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 396 JAPAN: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 397 JAPAN: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 398 JAPAN: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 399 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 400 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 401 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 402 JAPAN: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 403 JAPAN: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 404 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 Government initiatives and competitive nature of Indian pharmaceutical market to drive growth
    • TABLE 405 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 406 INDIA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 407 INDIA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 408 INDIA: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 409 INDIA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 410 INDIA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 411 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 412 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 413 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 414 INDIA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 415 INDIA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 416 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.4.4 SOUTH KOREA
      • 11.4.4.1 Increased export of drugs to affect market growth
    • TABLE 417 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 418 SOUTH KOREA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 419 SOUTH KOREA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 420 SOUTH KOREA: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 421 SOUTH KOREA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 422 SOUTH KOREA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 423 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 424 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 425 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 426 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 427 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 428 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.4.5 REST OF ASIA PACIFIC
    • TABLE 429 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 430 ROAPAC: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 431 ROAPAC: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 432 ROAPAC: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 433 ROAPAC: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 434 ROAPAC: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 435 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 436 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 437 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 438 ROAPAC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 439 ROAPAC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 440 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.4.6 ASIA PACIFIC: RECESSION IMPACT
  • 11.5 LATIN AMERICA
    • TABLE 441 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 442 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 443 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 444 LATIN AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 445 LATIN AMERICA: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 446 LATIN AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 447 LATIN AMERICA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 448 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 449 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 450 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 451 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 452 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 453 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.5.1 BRAZIL
      • 11.5.1.1 Growth of vaccine manufacturing to drive market
    • TABLE 454 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 455 BRAZIL: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 456 BRAZIL: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 457 BRAZIL: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 458 BRAZIL: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 459 BRAZIL: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 460 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 461 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 462 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 463 BRAZIL: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 464 BRAZIL: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 465 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.5.2 REST OF LATIN AMERICA
    • TABLE 466 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 467 ROLATAM: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 468 ROLATAM: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 469 ROLATAM: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 470 ROLATAM: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 471 ROLATAM: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 472 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 473 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 474 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 475 ROLATAM: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 476 ROLATAM: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 477 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.5.3 LATIN AMERICA: RECESSION IMPACT
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 SLOW AND EVOLVING BIOPHARMACEUTICAL INDUSTRY AND REGULATIONS TO HAMPER MARKET GROWTH
    • TABLE 478 MEA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 479 MEA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 480 MEA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2021-2028 (USD MILLION)
    • TABLE 481 MEA: DEPTH FILTERS MARKET, BY MEDIA, 2021-2028 (USD MILLION)
    • TABLE 482 MEA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 483 MEA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 484 MEA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 485 MEA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 486 MEA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 487 MEA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 488 MEA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 489 MEA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
    • 11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
    • FIGURE 33 PHARMACEUTICAL FILTRATION MARKET: STRATEGIES ADOPTED
  • 12.3 MARKET SHARE ANALYSIS
    • FIGURE 34 PHARMACEUTICAL FILTRATION MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
    • TABLE 490 PHARMACEUTICAL FILTRATION MARKET: DEGREE OF COMPETITION
  • 12.4 REVENUE ANALYSIS
    • FIGURE 35 REVENUE ANALYSIS FOR KEY COMPANIES (2020-2022)
  • 12.5 COMPANY EVALUATION MATRIX
    • FIGURE 36 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX, 2022
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
  • 12.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
    • 12.6.1 OVERALL FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 491 FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET
    • 12.6.2 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 492 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET
    • 12.6.3 TECHNIQUE FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 493 TECHNIQUE FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET
    • 12.6.4 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
    • TABLE 494 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET
  • 12.7 COMPANY EVALUATION MATRIX: START-UPS/SMES
    • FIGURE 37 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
    • 12.7.1 PROGRESSIVE COMPANIES
    • 12.7.2 STARTING BLOCKS
    • 12.7.3 RESPONSIVE COMPANIES
    • 12.7.4 DYNAMIC COMPANIES
  • 12.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES
    • TABLE 495 PHARMACEUTICAL FILTRATION MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 496 PHARMACEUTICAL FILTRATION MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • 12.9 COMPETITIVE SCENARIO AND TRENDS
    • 12.9.1 PRODUCT LAUNCHES
    • TABLE 497 PHARMACEUTICAL FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2019 TO JANUARY 2023
    • 12.9.2 DEALS
    • TABLE 498 PHARMACEUTICAL FILTRATION MARKET: DEALS, JANUARY 2019 TO JANUARY 2023
    • 12.9.3 EXPANSIONS
    • TABLE 499 PHARMACEUTICAL FILTRATION MARKET: EXPANSIONS, JANUARY 2019 TO JANUARY 2023

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**

    • 13.1.1 MERCK KGAA
    • TABLE 500 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2021)
    • 13.1.2 DANAHER CORPORATION
    • TABLE 501 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
    • 13.1.3 SARTORIUS AG
    • TABLE 502 SARTORIUS AG: BUSINESS OVERVIEW
    • FIGURE 40 SARTORIUS AG: COMPANY SNAPSHOT (2021)
    • 13.1.4 PARKER HANNIFIN CORPORATION
    • TABLE 503 PARKER HANNIFIN CORPORATION: BUSINESS OVERVIEW
    • FIGURE 41 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2022)
    • 13.1.5 EATON CORPORATION PLC
    • TABLE 504 EATON CORPORATION PLC: BUSINESS OVERVIEW
    • FIGURE 42 EATON CORPORATION PLC: COMPANY SNAPSHOT (2021)
    • 13.1.6 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 505 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
    • FIGURE 43 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
    • 13.1.7 3M COMPANY
    • TABLE 506 3M COMPANY: BUSINESS OVERVIEW
    • FIGURE 44 3M COMPANY: COMPANY SNAPSHOT (2021)
    • 13.1.8 DONALDSON COMPANY, INC.
    • TABLE 507 DONALDSON COMPANY, INC.: BUSINESS OVERVIEW
    • FIGURE 45 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2022)
    • 13.1.9 REPLIGEN CORPORATION
    • TABLE 508 REPLIGEN CORPORATION: BUSINESS OVERVIEW
    • FIGURE 46 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2021)
    • 13.1.10 PORVAIR PLC
    • TABLE 509 PORVAIR PLC: BUSINESS OVERVIEW
    • FIGURE 47 PORVAIR PLC: COMPANY SNAPSHOT (2021)
    • 13.1.11 ALFA LAVAL CORPORATE AB
    • TABLE 510 ALFA LAVAL CORPORATE AB: BUSINESS OVERVIEW
    • FIGURE 48 ALFA LAVAL CORPORATE AB: COMPANY SNAPSHOT (2021)
    • 13.1.12 CORNING INCORPORATED
    • TABLE 511 CORNING INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2021)
    • 13.1.13 MEISSNER FILTRATION PRODUCTS, INC.
    • TABLE 512 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW
    • 13.1.14 AMAZON FILTERS LTD.
    • TABLE 513 AMAZON FILTERS LTD.: BUSINESS OVERVIEW
    • 13.1.15 GRAVER TECHNOLOGIES, LLC.
    • TABLE 514 GRAVER TECHNOLOGIES, LLC.: BUSINESS OVERVIEW
  • 13.2 OTHER COMPANIES
    • 13.2.1 MMS AG
    • 13.2.2 MANN+HUMMEL INTERNATIONAL GMBH & CO. KG
    • 13.2.3 ERTELALSOP
    • 13.2.4 KASAG SWISS AG
    • 13.2.5 FREUDENBERG FILTRATION TECHNOLOGIES SE & CO. KG
    • 13.2.6 COLE-PARMER INSTRUMENT COMPANY, LLC
    • 13.2.7 CANTEL MEDICAL CORP.
    • 13.2.8 FILTROX AG
    • 13.2.9 SAINT-GOBAIN PERFORMANCE PLASTICS
    • 13.2.10 MEMBRANE SOLUTIONS
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS